Q301--Decipher Prostate Testing John D. Dingell VA Medical Center

The Department of Veterans Affairs awarded a sole-source contract to Veracyte Labs SD Corporation for Decipher Prostate Cancer Classifier testing services at the John D. Dingell VA Medical Center in Detroit, Michigan, under solicitation number 36C25026Q0063 and contract number 36C25026N0177. The award, issued on June 2, 2026, is based on FAR 13.106-1(b)(2), as Veracyte is the exclusive provider of the proprietary Decipher assay, eliminating any competitive sourcing opportunity. The contract has a base period of one year with four one-year option periods, potentially extending performance through June 1, 2031, and carries a base value of $243,044.25, with no pricing disclosed for option years. Service delivery involves genomic testing performed in Veracyte’s CLIA- and CAP-accredited laboratory in San Diego, California, while the place of performance remains the Detroit VA Medical Center where results are utilized for clinical decision-making. The contracting officer, Cierra S. Joshua, is the sole point of contact with no designated COR or COTR identified. The procurement followed a market survey process requiring respondents to submit only basic business information via email by October 24, 2025, with no formal proposal, page limits, or evaluation factors applied due to the non-competitive nature. Accreditation compliance is mandatory, and no packaging, marking, or FOB requirements apply as this is a service contract. The award does not involve recovery act funds, and the awardee has not claimed any socioeconomic status designations. Payment and accounting details are incomplete, though the agency code is 36C553, and all submissions must be made electronically to the contracting officer’s designated email address.